• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用抗间皮细胞抗体和计算机辅助定量分析来区分反应性和肿瘤性浆膜组织。

Use of antimesothelial cell antibody and computer assisted quantitative analysis for distinguishing between reactive and neoplastic serosal tissues.

作者信息

Donna A, Betta P G, Robutti F

机构信息

Department of Pathology, City Hospital, Alessandria, Italy.

出版信息

J Clin Pathol. 1987 Dec;40(12):1428-31. doi: 10.1136/jcp.40.12.1428.

DOI:10.1136/jcp.40.12.1428
PMID:3323251
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1141278/
Abstract

Nine malignant mesotheliomas and 12 specimens of benign reactive mesothelial hyperplasia were examined using a specific antimesothelial cell antibody. Immunostaining intensity was subsequently estimated by means of image analysis. The mean and standard deviation of integrated optical density in the malignant mesotheliomas differed significantly from those in the mesothelial hyperplasias. In all mesotheliomas but one the integrated optical density was greater than in reactive mesothelial hyperplasia. No significant difference in optical density was observed between the two groups; the standard deviation was significantly higher in the reactive lesions. This technique may be adopted to complement the traditional morphological assessment of primary lesions of the serosal cavities.

摘要

使用一种特异性抗间皮细胞抗体对9例恶性间皮瘤和12例良性反应性间皮增生标本进行了检测。随后通过图像分析估计免疫染色强度。恶性间皮瘤的积分光密度均值和标准差与间皮增生的均值和标准差有显著差异。除1例外,所有间皮瘤的积分光密度均高于反应性间皮增生。两组间光密度无显著差异;反应性病变的标准差显著更高。该技术可用于补充浆膜腔原发性病变的传统形态学评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a36f/1141278/4d1e91533cf6/jclinpath00332-0039-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a36f/1141278/4d1e91533cf6/jclinpath00332-0039-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a36f/1141278/4d1e91533cf6/jclinpath00332-0039-a.jpg

相似文献

1
Use of antimesothelial cell antibody and computer assisted quantitative analysis for distinguishing between reactive and neoplastic serosal tissues.使用抗间皮细胞抗体和计算机辅助定量分析来区分反应性和肿瘤性浆膜组织。
J Clin Pathol. 1987 Dec;40(12):1428-31. doi: 10.1136/jcp.40.12.1428.
2
Verification of the histologic diagnosis of malignant mesothelioma in relation to the binding of an antimesothelial cell antibody.关于抗间皮细胞抗体结合情况的恶性间皮瘤组织学诊断验证
Cancer. 1989 Apr 1;63(7):1331-6. doi: 10.1002/1097-0142(19890401)63:7<1331::aid-cncr2820630718>3.0.co;2-3.
3
The differential diagnosis of epithelial-type mesothelioma from adenocarcinoma and reactive mesothelial proliferation.上皮型间皮瘤与腺癌及反应性间皮增生的鉴别诊断。
J Pathol. 1991 Apr;163(4):299-305. doi: 10.1002/path.1711630406.
4
Newly marketed tissue markers for malignant mesothelioma: immunoreactivity of rabbit AMAD-2 antiserum compared with monoclonal antibody HBME-1 and a review of the literature on so-called antimesothelioma antibodies.恶性间皮瘤的新型市场组织标志物:兔AMAD - 2抗血清与单克隆抗体HBME - 1的免疫反应性及关于所谓抗间皮瘤抗体的文献综述
Hum Pathol. 1997 Aug;28(8):929-37. doi: 10.1016/s0046-8177(97)90008-3.
5
p53 immunostaining in the distinction between benign and malignant mesothelial proliferations using formalin-fixed paraffin sections.使用福尔马林固定石蜡切片,p53免疫染色在鉴别良性和恶性间皮增生中的应用
J Pathol. 1992 Dec;168(4):377-81. doi: 10.1002/path.1711680407.
6
Immunocytological staining reactions of anti-carcinoembryonic antigen, Ca, and anti-human milk fat globule monoclonal antibodies on benign and malignant exfoliated mesothelial cells.抗癌胚抗原、钙和抗人乳脂肪球单克隆抗体对良性和恶性脱落间皮细胞的免疫细胞化学染色反应。
J Clin Pathol. 1987 Dec;40(12):1424-7. doi: 10.1136/jcp.40.12.1424.
7
Immunohistochemical differentiation of malignant mesothelioma, mesothelial hyperplasia and metastatic adenocarcinoma in serous effusions, utilizing staining for carcinoembryonic antigen, keratin and vimentin.利用癌胚抗原、角蛋白和波形蛋白染色,对浆液性积液中恶性间皮瘤、间皮增生和转移性腺癌进行免疫组织化学鉴别。
Acta Cytol. 1987 Nov-Dec;31(6):807-14.
8
Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions.恶性间皮瘤:免疫组织化学和DNA倍体分析作为鉴别胸膜和腹膜积液中间皮瘤与良性反应性间皮细胞增生及腺癌的方法。
Arch Pathol Lab Med. 1996 Oct;120(10):959-66.
9
Utility of glucose transporter 1 in the distinction of benign and malignant thoracic and abdominal mesothelial lesions.葡萄糖转运蛋白 1 在鉴别良恶性胸腹腔间皮病变中的作用。
Arch Pathol Lab Med. 2012 Jul;136(7):804-9. doi: 10.5858/arpa.2011-0219-OA.
10
PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma.PAX8 可可靠地区分卵巢浆液性肿瘤和恶性间皮瘤。
Am J Surg Pathol. 2010 May;34(5):627-35. doi: 10.1097/PAS.0b013e3181da7687.

引用本文的文献

1
ME1. A monoclonal antibody that distinguishes epithelial-type malignant mesothelioma from pulmonary adenocarcinoma and extrapulmonary malignancies.ME1. 一种可区分上皮型恶性间皮瘤与肺腺癌及肺外恶性肿瘤的单克隆抗体。
Am J Pathol. 1990 Feb;136(2):421-8.

本文引用的文献

1
Quantitative and qualitative differences between benign and malignant mesothelial cells in pleural fluid.胸腔积液中良性与恶性间皮细胞的定量和定性差异。
Acta Cytol. 1982 Jul-Aug;26(4):401-6.
2
Interpretation of pleural biopsy specimens and aspirates with the immunoperoxidase technique.应用免疫过氧化物酶技术解读胸膜活检标本和抽吸物。
Thorax. 1982 Nov;37(11):822-7. doi: 10.1136/thx.37.11.822.
3
Immunocytochemical staining of cells in pleural and peritoneal effusions with a panel of monoclonal antibodies.用一组单克隆抗体对胸腔积液和腹腔积液中的细胞进行免疫细胞化学染色。
J Clin Pathol. 1983 Oct;36(10):1154-64. doi: 10.1136/jcp.36.10.1154.
4
Indirect immunoalkaline phosphatase staining of cytologic smears of serous effusions for tumor marker studies.用于肿瘤标志物研究的浆液性积液细胞涂片的间接免疫碱性磷酸酶染色。
Acta Cytol. 1983 Mar-Apr;27(2):109-13.
5
Histologic distinction between malignant mesothelioma, benign pleural lesion and carcinoma metastasis. Evaluation of the application of morphometry combined with histochemistry and immunostaining.
Virchows Arch A Pathol Anat Histol. 1982;397(3):287-99. doi: 10.1007/BF00496570.
6
Use of two epithelium-specific monoclonal antibodies for diagnosis of malignancy in serous effusions.使用两种上皮特异性单克隆抗体诊断浆液性积液中的恶性肿瘤。
Lancet. 1982 Nov 6;2(8306):1004-6. doi: 10.1016/s0140-6736(82)90047-2.
7
A new marker for human cancer cells. 3. Immunocytochemical detection of malignant cells in serous fluids with the Ca1 antibody.一种人类癌细胞的新标志物。3. 用Ca1抗体对浆液性液体中的恶性细胞进行免疫细胞化学检测。
Lancet. 1982 Sep 4;2(8297):512-4. doi: 10.1016/s0140-6736(82)90598-0.
8
Use of antibodies to carcinoembryonic antigen and human milk fat globule to distinguish carcinoma, mesothelioma, and reactive mesothelium.
J Clin Pathol. 1984 Nov;37(11):1215-21. doi: 10.1136/jcp.37.11.1215.
9
Isolation and characterization of a possible new protein marker for differential diagnosis between metastatic carcinoma and mesothelioma cells in serous effusions: preliminary findings.一种可能用于鉴别诊断浆液性积液中转移性癌和间皮瘤细胞的新型蛋白质标志物的分离与鉴定:初步研究结果
Cancer Detect Prev. 1985;8(1-2):255-60.
10
New marker for mesothelioma: an immunoperoxidase study.间皮瘤的新标志物:一项免疫过氧化物酶研究。
J Clin Pathol. 1986 Sep;39(9):961-8. doi: 10.1136/jcp.39.9.961.